Royal Bank of Canada’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-85
Closed -$1K 8111
2021
Q3
$1K Buy
85
+77
+963% +$765 ﹤0.01% 7554
2021
Q2
$0 Sell
8
-182
-96% -$1.82K ﹤0.01% 7829
2021
Q1
$2K Buy
+190
New +$1.93K ﹤0.01% 7268

Other funds holding EQHA.U

Royal Bank of Canada's EQHA.U Position: Q4 2021 in Review

Royal Bank of Canada sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2021, closing a stake of 85 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in EQHA.U in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q1 2021. 23 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2021.

  • Royal Bank of Canada reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 85 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2021, an estimated $1K.
  • Royal Bank of Canada first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • Royal Bank of Canada's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $2K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2021.

Based on Royal Bank of Canada's 13F filing for Q4 2021, filed 14 Feb 2022.